Correction: Siltuximab as a first-line therapy for idiopathic multicentric Castleman disease: a retrospective analysis based on the SiMuLa study of the Italian regional network

Frontiers in Oncology 2026 Open access

Read full text
Authors: S. Pelliccia, A. Di Rocco, G. Palumbo, A. Zizzari, Ombretta Annibali, E. Maiolo, A. Rago, Giulio Trapè, M. P. Bianchi, G. Pileggi, L. Filomeno, Stefan Hohaus
+6 more L. Rigacci, M. C. Cox, M. Martelli, Giacinto La Verde, A. Di Napoli, Agostino Tafuri
DOI: 10.3389/fonc.2026.1812268
Cited by: 1

Abstract

retrospective analysis based on the SiMuLa study of the Italian regional network

Fields of Study & Subjects

Viral-associated cancers and disorders Multiple Myeloma Research and Treatments Chronic Lymphocytic Leukemia Research

Publication details

Journal / source
Frontiers in Oncology
Publisher
Frontiers Media SA
Volume
16
Pages
1812268–1812268
Publication date
11 March 2026
Language
EN